Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke.

Wigner P, Saluk-Bijak J, Synowiec E, Miller E, Sliwinski T, Cichon N, Bijak M.

J Clin Med. 2019 Dec 3;8(12). pii: E2133. doi: 10.3390/jcm8122133.


Evaluation of the effects of extremely low frequency electromagnetic field on the levels of some inflammatory cytokines in post-stroke patients.

Cichon N, Saluk-Bijak J, Miller E, Sliwinski T, Synowiec E, Wigner P, Bijak M.

J Rehabil Med. 2019 Dec 16;51(11):854-860. doi: 10.2340/16501977-2623.


Plasma MicroRNA as a novel diagnostic.

Szelenberger R, Kacprzak M, Saluk-Bijak J, Zielinska M, Bijak M.

Clin Chim Acta. 2019 Dec;499:98-107. doi: 10.1016/j.cca.2019.09.005. Epub 2019 Sep 6. Review.


Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery.

Szelenberger R, Kostka J, Saluk-Bijak J, Miller E.

Curr Neuropharmacol. 2020;18(1):51-64. doi: 10.2174/1570159X17666190726104139.


A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.

Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M.

Nutrients. 2019 Jul 5;11(7). pii: E1528. doi: 10.3390/nu11071528. Review.


Blood platelet surface receptor genetic variation and risk of thrombotic episodes.

Szelenberger R, Kacprzak M, Bijak M, Saluk-Bijak J, Zielinska M.

Clin Chim Acta. 2019 Sep;496:84-92. doi: 10.1016/j.cca.2019.06.020. Epub 2019 Jun 22. Review.


Biological Toxins as the Potential Tools for Bioterrorism.

Janik E, Ceremuga M, Saluk-Bijak J, Bijak M.

Int J Mol Sci. 2019 Mar 8;20(5). pii: E1181. doi: 10.3390/ijms20051181. Review.


Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients.

Bijak M, Olejnik A, Rokita B, Morel A, Dziedzic A, Miller E, Saluk-Bijak J.

J Cell Mol Med. 2019 May;23(5):3476-3482. doi: 10.1111/jcmm.14244. Epub 2019 Mar 5.


Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients.

Cichon N, Bijak M, Synowiec E, Miller E, Sliwinski T, Saluk-Bijak J.

Scand J Clin Lab Invest. 2018 Nov - Dec;78(7-8):626-631. doi: 10.1080/00365513.2018.1542540.


Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis.

Saluk-Bijak J, Dziedzic A, Bijak M.

Cells. 2019 Feb 1;8(2). pii: E110. doi: 10.3390/cells8020110. Review.


Dual Anticoagulant/Antiplatelet Activity of Polyphenolic Grape Seeds Extract.

Bijak M, Sut A, Kosiorek A, Saluk-Bijak J, Golanski J.

Nutrients. 2019 Jan 5;11(1). pii: E93. doi: 10.3390/nu11010093.


Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients.

Cichoń N, Bijak M, Czarny P, Miller E, Synowiec E, Sliwinski T, Saluk-Bijak J.

Front Aging Neurosci. 2018 Sep 26;10:294. doi: 10.3389/fnagi.2018.00294. eCollection 2018.


The potential contribution and role of a blood platelets in autoimmune thyroid diseases.

Tomczyńska M, Salata I, Bijak M, Saluk-Bijak J.

J Cell Mol Med. 2018 Dec;22(12):6386-6390. doi: 10.1111/jcmm.13862. Epub 2018 Sep 6.


The mutual cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases.

Tomczyńska M, Saluk-Bijak J.

Acta Biochim Pol. 2018;65(1):17-24. doi: 10.18388/abp.2017_2321. Epub 2018 Mar 15. Review.


Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.

Bijak M, Szelenberger R, Dziedzic A, Saluk-Bijak J.

Molecules. 2018 Feb 10;23(2). pii: E374. doi: 10.3390/molecules23020374.


Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.

Bijak M, Synowiec E, Sitarek P, Sliwiński T, Saluk-Bijak J.

Nutrients. 2017 Dec 14;9(12). pii: E1356. doi: 10.3390/nu9121356.


Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation.

Cichoń N, Czarny P, Bijak M, Miller E, Śliwiński T, Szemraj J, Saluk-Bijak J.

Oxid Med Cell Longev. 2017;2017:2181942. doi: 10.1155/2017/2181942. Epub 2017 Sep 12.


Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.

Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk-Bijak J.

Nutrients. 2017 Sep 15;9(9). pii: E1022. doi: 10.3390/nu9091022.


Flavonolignans reduce the response of blood platelet to collagen.

Bijak M, Dziedzic A, Saluk-Bijak J.

Int J Biol Macromol. 2018 Jan;106:878-884. doi: 10.1016/j.ijbiomac.2017.08.091. Epub 2017 Aug 23.


Flavonolignans inhibit the arachidonic acid pathway in blood platelets.

Bijak M, Saluk-Bijak J.

BMC Complement Altern Med. 2017 Aug 10;17(1):396. doi: 10.1186/s12906-017-1897-7.

Supplemental Content

Loading ...
Support Center